Goldenwell Biotech, Inc. income statement GWLL

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Goldenwell Biotech, Inc. reported revenue of $55, down 60.4% from the year before. It recorded a net loss of $296,471. The operating loss came to $113,326, an operating margin of -206047.3%. Diluted earnings per share were $0.00. Over the twelve months ended Mar 31, 2026, revenue was $55 and the net loss was $275,541. Across the 5 fiscal years shown, revenue shrank from $15,967 in fiscal 2021 to $55 in fiscal 2025, about 75.8% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Mar 31, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Revenue	0 -60.4%	0 -60.4%	0 -94.1%	0 -95.1%	0 +199.4%	0	0
Cost of revenue	0 -42.7%	0 -42.7%	0 -93.6%	0 -94.8%	0 +198.4%	0	0
Gross profit	0 -81.2%	0 -81.2%	0 -90.4%	0 -97.4%	0 +200.3%	0	0
Selling, general and administrative	0 -17.1%	0 -8.0%	0 +5.7%	0 -88.5%	1 +697.7%	0 +1888.9%	0
Operating expenses	0 -17.1%	0 -8.0%	0 +5.7%	0 -88.5%	1	—	—
Operating income	-0 +17.1%	-0 +7.9%	-0 -6.3%	-0 +88.2%	-1	—	—
Pretax income	—	—	-0	—	—	-0 -1757.2%	-0
Income tax	0	0	0	0	0	0	0
Net income	-0 -98.1%	-0 -125.5%	-0 -12.0%	-0 +88.1%	-1 -742.1%	-0 -1749.8%	-0
Diluted EPS	-0.00	0.00	0.00	—	—	—	—
Weighted average shares, diluted	99	99 +0.0%	99	—	—	—	—
Other measures
Interest coverage	-12.88x	-13.49x	-14.65x	—	—	—	—
Margins
Gross margin	21.82%	21.82%	46.04%	28.46%	52.69%	52.53%	—
Operating margin	-196,772.73%	-206,047.27%	-88,559.71%	-4,949.83%	-2,060.89%	—	—
Pretax margin	—	—	-94,602.88%	—	—	-740.70%	—
Profit margin	-500,983.64%	-539,038.18%	-94,602.88%	-5,015.43%	-2,060.87%	-732.64%	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Food and Kindred Products (SIC 2000)
Listed as: GWLL (OTC)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: Solon, OH
SEC filer status: , Emerging growth company
SEC CIK: 1800373

Other Food and Kindred Products companies

All 27 Food and Kindred Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.